3 Dividend Stocks to Buy Before September Ends and Hold Forever
Coca-Cola, PepsiCo, and AbbVie are highlighted for their strong dividend histories, recent guidance raises, and recession-resilient business models. Coca-Cola expects 5% organic revenue growth and 9-10% EPS growth. PepsiCo yields 4.31% and raised its dividend for 54 consecutive years. AbbVie, despite a high P/E, has a strong free cash flow yield and raised its full-year revenue guidance. All three are recommended for income investors.
How this was made
The 30-second read
Why it matters
While each company reports modest guidance lifts and dividend hikes, the overall catalyst is limited to income‑oriented positioning rather than a material market‑moving event.
Market read
Income‑focused investors may consider these stocks, but the article offers limited actionable insight beyond standard dividend updates.
What to watch
Potential headwinds from consumer softness and drug biosimilar competition could pressure earnings.
Background
The article lists three dividend‑paying stocks with recent earnings, guidance updates, and dividend increases, targeting investors seeking long‑term income.
Ticker impact
PepsiCo announced a 4% dividend increase and guidance for 2026 cash returns of ~$8.9B.
Small upside pressure if investors value higher yield.
Higher dividend and cash return guidance may attract income investors, but limited catalyst.
AbbVie reported Q2 2026 revenue up 10.2% and raised FY26 adjusted EPS guidance to $13.87‑$14.07.
Modest upside if market credits cash flow strength.
Improved earnings outlook and dividend growth may appeal to yield‑seeking investors.
Coca‑Cola raised its full‑year 2026 outlook and reported Q2 revenue of $13.38B, beating expectations.
Slight upside as investors note stronger momentum.
Higher revenue and dividend continuity reinforce its defensive appeal.
Market effects
Highlights dividend‑heavy consumer staples and pharma as attractive for income investors.
U.S. market focus; no specific regional effect.
Reinforces defensive positioning globally amid recession concerns.
Counterpoint
Yield may be insufficient given high valuations; growth risks could outweigh dividend appeal.
Key entities
- CompanyPepsiCo
Snack and beverage maker with raised dividend and cash‑return guidance.
- CompanyAbbVie
Pharma firm with improved Q2 results and higher FY26 EPS outlook.
- CompanyCoca‑Cola
Beverage giant with raised full‑year outlook and dividend continuity.
